Quality of Life assessment through the EORTC questionnaires of colorectal cancer patients in advanced disease stages
- PMID: 17005468
- DOI: 10.1007/s12094-006-0036-6
Quality of Life assessment through the EORTC questionnaires of colorectal cancer patients in advanced disease stages
Abstract
Purpose: The purpose of the present work is to evaluate Quality of Life in a group of colorectal cancer patients in advanced stages of their disease, along a standard chemotherapy treatment protocol, through the EORTC core questionnaire QLQ-C30 and the colorectal cancer module QLQ-CR38. These two questionnaires had previously been validated in our country. The present study has the novelty of its use during the chemotherapy treatment.
Materials and methods: A consecutive sample of 44 colon o rectal cancer patients in stage IV, from an initial group of 46 patients who were addressed, have filled in the questionnaires, in three moments during their treatment process. Clinical and demographic data have also been recorded. Quality of Life scores and changes in them among the three assessments have been calculated.
Results: The quality of life scores of patients who have followed the treatment have been >70 points (100) in most dimensions, and has shown similar to the clinical data. Changes of >20 points in the quality of life scores during the treatment process appear in areas related to toxicity, fatigue and insomnia. Quality of life has been stable or has had small changes (between 10 and 20 points) in most dimensions.
Conclusions: Quality of Life in the present sample has been good in general. The treatment has been administered to patients who could tolerate it adequately.
Similar articles
-
Quality of Life assessment through the EORTC questionnaires of locally advanced rectal cancer patients treated with preoperative chemo-radiotherapy.Clin Transl Oncol. 2006 Jun;8(6):423-9. doi: 10.1007/s12094-006-0196-4. Clin Transl Oncol. 2006. PMID: 16790395
-
Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer.Health Qual Life Outcomes. 2011 Aug 22;9:70. doi: 10.1186/1477-7525-9-70. Health Qual Life Outcomes. 2011. PMID: 21859485 Free PMC article.
-
The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.Eur J Cancer. 1999 Feb;35(2):238-47. doi: 10.1016/s0959-8049(98)00357-8. Eur J Cancer. 1999. PMID: 10448266
-
Comparison of the FACT-C, EORTC QLQ-CR38, and QLQ-CR29 quality of life questionnaires for patients with colorectal cancer: a literature review.Support Care Cancer. 2016 Aug;24(8):3661-8. doi: 10.1007/s00520-016-3270-7. Epub 2016 May 18. Support Care Cancer. 2016. PMID: 27193118 Review.
-
Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer.Eur J Cancer. 2003 Jun;39(9):1259-63. doi: 10.1016/s0959-8049(03)00236-3. Eur J Cancer. 2003. PMID: 12763214 Review.
Cited by
-
Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer.World J Gastroenterol. 2017 Mar 14;23(10):1891-1898. doi: 10.3748/wjg.v23.i10.1891. World J Gastroenterol. 2017. PMID: 28348496 Free PMC article.
-
Carfilzomib (Kyprolis): A Novel Proteasome Inhibitor for Relapsed And/or Refractory Multiple Myeloma.P T. 2016 May;41(5):303-7. P T. 2016. PMID: 27162470 Free PMC article. No abstract available.
-
The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients.Clin Transl Oncol. 2009 Mar;11(3):160-4. doi: 10.1007/s12094-009-0332-z. Clin Transl Oncol. 2009. PMID: 19293053
-
The EORTC Quality of Life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients.Clin Transl Oncol. 2011 Jan;13(1):50-6. doi: 10.1007/s12094-011-0616-y. Clin Transl Oncol. 2011. PMID: 21239355
References
Publication types
MeSH terms
LinkOut - more resources
Medical